HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miguel A Barbancho Selected Research

Miguel A Barbancho Research Topics

Disease

3Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2019
3Cognitive Dysfunction
11/2019 - 08/2014
2Aphasia (Dysphasia)
06/2015 - 05/2009
1Heart Failure
01/2022
1Dyspnea (Shortness of Breath)
01/2022
1Hyperglycemia
04/2021
1Postoperative Cognitive Complications
11/2019
1Critical Illness (Critically Ill)
05/2019
1Stroke (Strokes)
06/2015
1Diabetes Mellitus
03/2015
1Obesity
03/2015
1Coronary Artery Disease (Coronary Atherosclerosis)
08/2014

Drug/Important Bio-Agent (IBA)

3Insulin (Novolin)FDA Link
01/2022 - 05/2019
2Blood Glucose (Blood Sugar)IBA
04/2021 - 05/2019
2LinagliptinIBA
04/2021 - 05/2019
2Memantine (Namenda)FDA Link
06/2015 - 05/2009
1pro-brain natriuretic peptide (1-76)IBA
01/2022
1empagliflozinIBA
01/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022
1DiureticsIBA
01/2022
1Sodium-Glucose Transport ProteinsIBA
01/2022
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2021
1hemoglobin P (Hb P)IBA
03/2015
1Hemoglobins (Hemoglobin)IBA
08/2014
1Pharmaceutical PreparationsIBA
05/2009

Therapy/Procedure

4Therapeutics
04/2021 - 05/2009
2Injections
04/2021 - 05/2019
1Length of Stay
01/2022
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2019
1Perioperative Care
11/2019
1Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump)
03/2015